STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UnitedHealth Group Inc. (UNH) – Form 4 filing, 26 Jun 2025: President & CFO John F. Rex reported an automatic acquisition of 131.931 common shares on 24 Jun 2025. The shares represent dividend-equivalent units credited on outstanding restricted stock units; no cash outlay was made (price = $0).

Following the credit, Rex directly owns 203,898.467 shares and indirectly owns 6,791 shares via a trust. No derivative transactions, open-market purchases, or sales were disclosed. The filing is routine and does not reflect a discretionary investment decision.

UnitedHealth Group Inc. (UNH) – Comunicazione Form 4, 26 giugno 2025: Il Presidente e CFO John F. Rex ha segnalato un'acquisizione automatica di 131.931 azioni ordinarie il 24 giugno 2025. Le azioni rappresentano unità equivalenti a dividendi accreditate su unità azionarie vincolate in essere; non è stato effettuato alcun esborso in contanti (prezzo = 0$).

Dopo l'accredito, Rex possiede direttamente 203.898,467 azioni e indirettamente 6.791 azioni tramite un trust. Non sono state dichiarate transazioni su derivati, acquisti sul mercato aperto o vendite. La comunicazione è di routine e non riflette una decisione di investimento discrezionale.

UnitedHealth Group Inc. (UNH) – Presentación Formulario 4, 26 de junio de 2025: El presidente y CFO John F. Rex reportó una adquisición automática de 131,931 acciones comunes el 24 de junio de 2025. Las acciones representan unidades equivalentes a dividendos acreditadas sobre unidades restringidas de acciones pendientes; no se realizó ningún desembolso en efectivo (precio = 0$).

Tras el abono, Rex posee directamente 203,898.467 acciones y posee indirectamente 6,791 acciones a través de un fideicomiso. No se divulgaron transacciones con derivados, compras en mercado abierto ni ventas. La presentación es rutinaria y no refleja una decisión de inversión discrecional.

UnitedHealth Group Inc. (UNH) – Form 4 제출, 2025년 6월 26일: 사장 겸 CFO John F. Rex가 2025년 6월 24일에 131,931 보통주 자동 취득을 보고했습니다. 해당 주식은 미결 제한 주식 단위에 대해 배당금과 동일한 단위로 적립된 것이며, 현금 지출은 없었습니다(가격 = $0).

적립 후 Rex는 직접 203,898.467주를 소유하고 있으며, 신탁을 통해 간접적으로 6,791주를 보유하고 있습니다. 파생상품 거래, 공개 시장 매수 또는 매도는 보고되지 않았습니다. 이번 제출은 일상적인 것으로 임의 투자 결정과는 관련이 없습니다.

UnitedHealth Group Inc. (UNH) – Déclaration Formulaire 4, 26 juin 2025 : Le président et directeur financier John F. Rex a déclaré une acquisition automatique de 131 931 actions ordinaires le 24 juin 2025. Ces actions représentent des unités équivalentes aux dividendes créditées sur des unités d’actions restreintes en circulation ; aucune dépense en espèces n’a été effectuée (prix = 0$).

Après ce crédit, Rex détient directement 203 898,467 actions et indirectement 6 791 actions via un trust. Aucune transaction sur dérivés, achat sur le marché libre ou vente n’a été divulguée. Cette déclaration est de routine et ne reflète pas une décision d’investissement discrétionnaire.

UnitedHealth Group Inc. (UNH) – Form 4 Meldung, 26. Juni 2025: Präsident und CFO John F. Rex meldete am 24. Juni 2025 den automatischen Erwerb von 131.931 Stammaktien. Die Aktien stellen dividendenäquivalente Einheiten dar, die auf ausstehenden Restricted Stock Units gutgeschrieben wurden; es erfolgte kein Barausgleich (Preis = 0$).

Nach der Gutschrift besitzt Rex direkt 203.898,467 Aktien und indirekt 6.791 Aktien über einen Trust. Keine Derivatgeschäfte, Käufe am offenen Markt oder Verkäufe wurden offengelegt. Die Meldung ist routinemäßig und stellt keine diskretionäre Investitionsentscheidung dar.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine dividend-equivalent credit; immaterial change, neutral impact.

The reported transaction is a standard credit of dividend-equivalent shares linked to previously granted RSUs. With only 132 shares added (<0.1% of Rex’s holdings), and no cash consideration, the filing provides little insight into management’s sentiment or operational performance. Total direct ownership rises marginally to ~204k shares, maintaining alignment with shareholders but not signaling fresh commitment. Market impact is expected to be negligible.

UnitedHealth Group Inc. (UNH) – Comunicazione Form 4, 26 giugno 2025: Il Presidente e CFO John F. Rex ha segnalato un'acquisizione automatica di 131.931 azioni ordinarie il 24 giugno 2025. Le azioni rappresentano unità equivalenti a dividendi accreditate su unità azionarie vincolate in essere; non è stato effettuato alcun esborso in contanti (prezzo = 0$).

Dopo l'accredito, Rex possiede direttamente 203.898,467 azioni e indirettamente 6.791 azioni tramite un trust. Non sono state dichiarate transazioni su derivati, acquisti sul mercato aperto o vendite. La comunicazione è di routine e non riflette una decisione di investimento discrezionale.

UnitedHealth Group Inc. (UNH) – Presentación Formulario 4, 26 de junio de 2025: El presidente y CFO John F. Rex reportó una adquisición automática de 131,931 acciones comunes el 24 de junio de 2025. Las acciones representan unidades equivalentes a dividendos acreditadas sobre unidades restringidas de acciones pendientes; no se realizó ningún desembolso en efectivo (precio = 0$).

Tras el abono, Rex posee directamente 203,898.467 acciones y posee indirectamente 6,791 acciones a través de un fideicomiso. No se divulgaron transacciones con derivados, compras en mercado abierto ni ventas. La presentación es rutinaria y no refleja una decisión de inversión discrecional.

UnitedHealth Group Inc. (UNH) – Form 4 제출, 2025년 6월 26일: 사장 겸 CFO John F. Rex가 2025년 6월 24일에 131,931 보통주 자동 취득을 보고했습니다. 해당 주식은 미결 제한 주식 단위에 대해 배당금과 동일한 단위로 적립된 것이며, 현금 지출은 없었습니다(가격 = $0).

적립 후 Rex는 직접 203,898.467주를 소유하고 있으며, 신탁을 통해 간접적으로 6,791주를 보유하고 있습니다. 파생상품 거래, 공개 시장 매수 또는 매도는 보고되지 않았습니다. 이번 제출은 일상적인 것으로 임의 투자 결정과는 관련이 없습니다.

UnitedHealth Group Inc. (UNH) – Déclaration Formulaire 4, 26 juin 2025 : Le président et directeur financier John F. Rex a déclaré une acquisition automatique de 131 931 actions ordinaires le 24 juin 2025. Ces actions représentent des unités équivalentes aux dividendes créditées sur des unités d’actions restreintes en circulation ; aucune dépense en espèces n’a été effectuée (prix = 0$).

Après ce crédit, Rex détient directement 203 898,467 actions et indirectement 6 791 actions via un trust. Aucune transaction sur dérivés, achat sur le marché libre ou vente n’a été divulguée. Cette déclaration est de routine et ne reflète pas une décision d’investissement discrétionnaire.

UnitedHealth Group Inc. (UNH) – Form 4 Meldung, 26. Juni 2025: Präsident und CFO John F. Rex meldete am 24. Juni 2025 den automatischen Erwerb von 131.931 Stammaktien. Die Aktien stellen dividendenäquivalente Einheiten dar, die auf ausstehenden Restricted Stock Units gutgeschrieben wurden; es erfolgte kein Barausgleich (Preis = 0$).

Nach der Gutschrift besitzt Rex direkt 203.898,467 Aktien und indirekt 6.791 Aktien über einen Trust. Keine Derivatgeschäfte, Käufe am offenen Markt oder Verkäufe wurden offengelegt. Die Meldung ist routinemäßig und stellt keine diskretionäre Investitionsentscheidung dar.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
REX JOHN F

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President & CFO
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 131.931(1) A $0 203,898.467 D
Common Stock 6,791 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for John F. Rex 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many UnitedHealth (UNH) shares did CFO John F. Rex acquire on 24 Jun 2025?

131.931 shares were credited as dividend-equivalent units linked to restricted stock.

What is John F. Rex’s total direct ownership in UNH after the Form 4 transaction?

He now directly owns 203,898.467 UNH shares.

Was cash paid for the newly acquired UNH shares?

No. The shares were credited at $0 as dividend equivalents; no cash was exchanged.

Did the Form 4 disclose any sales of UNH stock?

No sales were reported; the filing only shows a minor acquisition.

Does this filing indicate a new 10b5-1 trading plan for UNH insiders?

The form does not indicate a new 10b5-1 plan; the transaction was an automatic dividend-equivalent credit.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

273.97B
904.46M
0.24%
90.3%
0.95%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
EDEN PRAIRIE